Lead Product(s) : Tryptophan
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Sponsor : Mitsubishi Tanabe Pharma | National Institute of Mental Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Tryptophan MRI in People With Schizophrenia and Healthy Controls
Details : Tryptophan is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Schizophrenia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 20, 2014
Lead Product(s) : Tryptophan
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Sponsor : Mitsubishi Tanabe Pharma | National Institute of Mental Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
